First U.S. patient receives autologous stem cell therapy to treat dry AMD
[ad_1] The National Institutes of Health (NIH) announced the first patient has been treated in its phase 1/2a clinical trial (NCT04339764) of an autologous induced pluripotent stem cell (iPSC) therapy for the treatment of dry age-related macular degeneration (AMD).1 According to an NIH news release, the patient received the therapy as part of a clinical…
Read More
Research focuses on retinal issues following COVID-19 infection
[ad_1] Retinal involvement following a COVID-19 infection is rare but can happen after severe infections in immunocompetent individuals, according to Yusar Asad, MD, and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India. The research team conducted a retrospective review of consecutive patients presenting with retinal manifestations attributable to COVID 19 between May 2020…
Read More
More than 26,000 eye injuries related to sports treated last year
[ad_1] Prevent Blindness has declared September as Sports Eye Safety Month to help educate the public on the importance of wearing the proper eye protection while playing sports. According to data from Prevent Blindness, there were more than 26,000 sports-related eye injuries treated in the United States last year. The new data also showed that…
Read More
Alternative topical ocular antiseptic lowers bacterial load with less pain
[ad_1] Reviewed by Thomas W. Hejkal, MD, PhD Because many people are very sensitive to povidone-iodine 5% (Betadine; Alcon), Thomas Hejkal, MD, PhD, and colleagues set out to identify an alternative ocular antiseptic with the potential to cause fewer ocular problems for their patients that is also as effective at eradicating surface bacteria. Hejkal is…
Read More
Gene therapy for completely colorblind children partly restores cone function
[ad_1] Gene therapy has partly restored the function of the retina’s cone receptors in two children who were born completely colorblind, reports a new study led by UCL researchers. The findings, published in Brain,1 provide hope that the treatment is effectively activating previously dormant communication pathways between the retina and the brain, drawing on the plastic…
Read More
Caffeine metabolite may slow progression of myopia in children
[ad_1] The progression of myopia in children may be slowed by a metabolite of caffeine, known as 7-MX, according to observational research published online in the British Journal of Ophthalmology.1 If proved safe and effective in large clinical trials, 7-MX could become a valuable treatment for a condition for which current options are somewhat limited, say…
Read More
Moving past the eyes and into the brain
[ad_1] Reviewed by Lotfi Merabet, OD, PhD, MPH, and Jessie Cronan Cortical/cerebral visual impairment (CVI), a condition related to brain injury, is visual impairment resulting from damage to the visual pathways in the brain. Unfortunately, CVI is all too common although not frequently diagnosed. And therein lies the problem. CVI is the leading cause of…
Read More
Screen and treat unstable tear film in weeks
[ad_1] Patient expectations for cataract surgery are very high, especially when it comes to advanced-technology implants. To meet those expectations, we need accurate preoperative measurements as a basis for intraocular lens calculations, and we can’t have accurate measurements without a stable tear film. Objective tests such as tear osmolarity and matrix metalloproteinase 9 (MMP-9) offer…
Read More
Cryopreserved amniotic membrane an option treatment of mechanical dry eye
[ad_1] Characterized by loose, redundant conjunctival folds, conjunctivochalasis (CCH), also known as mechanical dry eye (MDE), is a chronic condition that typically affects both eyes and is a common cause of ocular irritation and discomfort.1,2 CCH is associated with various ocular and non-ocular conditions, but it is often overlooked and underdiagnosed in clinical practice as…
Read More
APOE gene linked to Alzheimer’s may prevent retinal ganglion cell death
[ad_1] Research led by scientists at Mass Eye and Ear and Brigham and Women’s Hospital, member hospitals of Mass General Brigham, uncovers the role that a genetic variant linked with Alzheimer’s disease, APOE4, plays in protecting against glaucoma. According to a news release from Mass Ear and Eye, in the study published August 16 in…
Read More
Our Location
121 E 61st St.
New York, NY 10065
© Belmont Eye Center all rights reserved 2025. Designed by Glacial Multimedia.
If you are using a screen reader and are having problems using this website, please call 212.486.2020.